Influenza virus partially counteracts restriction imposed by tetherin/BST-2

Journal of Biological Chemistry

Volumn 287, Issue 26, 2012, Pages 22015-22029

  Mangeat, Bastien ^a,b   Cavagliotti, Lorris ^b   Lehmann, Martin ^b   Gers Huber, Gustavo ^b   Kaur, Inderdeep ^b   Thomas, Yves ^b   Kaiser, Laurent ^b   Piguet, Vincent ^a,b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITIES; CELL SURFACES; CELLULAR FACTORS; CELLULAR PROTEINS; ECTOPIC EXPRESSIONS; ENVELOPED VIRUS; HOST CELLS; HUMAN RESPIRATORY TRACT; INFLUENZA VIRUS; NEURAMINIDASE; RAPID CONTROL; STEADY-STATE LEVEL; SURFACE PROTEINS; TYPE I INTERFERONS; VIRAL PARTICLES; VIRAL PRODUCTION;

CELL MEMBRANES; ONCOGENIC VIRUSES; PROTEINS;

DISEASES;

CELL PROTEIN; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; NONSTRUCTURAL PROTEIN 1; PROTEIN ADAR1; PROTEIN ISG15; SIALIDASE; TETHERIN; UNCLASSIFIED DRUG; VIPERIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; STEADY STATE; VIRION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; CELL LINE; CELL LINE, TUMOR; DOGS; GENE EXPRESSION REGULATION, VIRAL; GLYCOSIDE HYDROLASES; GPI-LINKED PROTEINS; HELA CELLS; HUMANS; INFLUENZA, HUMAN; MICROSCOPY, ELECTRON; MODELS, BIOLOGICAL; ORTHOMYXOVIRIDAE; PLASMIDS; RNA INTERFERENCE; SUBTILISIN;

EID: 84862651351     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.319996     Document Type: Article

References (68)

1. Lambert, L. C., and Fauci, A. S. (2010) Influenza vaccines for the future. N. Engl. J. Med. 363, 2036-2044
2. Neuzil, K. M., Zhu, Y., Griffin, M. R., Edwards, K. M., Thompson, J. M., Tollefson, S. J., and Wright, P. F. (2002) Burden of interpandemic influenza in children younger than 5 years. A 25-year prospective study. J. Infect. Dis. 185, 147-152
3. Taubenberger, J. K., and Kash, J. C. (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7, 440-451
4. Hayashi, S., Jibiki, I., Asai, Y., Gon, Y., Kobayashi, T., Ichiwata, T., Shimizu, K., and Hashimoto, S. (2008) Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase. Respirology 13, 203-214
5. Xu, W., Zheng, S., Goggans, T. M., Kiser, P., Quinones-Mateu, M. E., Janocha, A. J., Comhair, S. A., Slee, R., Williams, B. R., and Erzurum, S. C. (2006) Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection. J. Interferon Cytokine Res. 26, 609-627
6. Tong, H. H., Long, J. P., Li, D., and DeMaria, T. F. (2004) Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb. Pathog. 37, 193-204
7. Kaiser, L., Fritz, R. S., Straus, S. E., Gubareva, L., and Hayden, F. G. (2001) Symptom pathogenesis during acute influenza. Interleukin-6 and other cytokine responses. J. Med. Virol. 64, 262-268
8. Richman, D. D., Murphy, B. R., Baron, S., and Uhlendorf, C. (1976) Three strains of influenza A virus (H3N2). Interferon sensitivity in vitro and interferon production in volunteers. J. Clin. Microbiol. 3, 223-226
9. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, C. S., Reis e Sousa, C., Matsuura, Y., Fujita, T., and Akira, S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105
10. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C. (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531
11. García-Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., and Durbin, J. E. (1998) The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550-8558
12. Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W., and Straus, S. E. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649
13. Moltedo, B., López, C. B., Pazos, M., Becker, M. I., Hermesh, T., and Moran, T. M. (2009) Cutting edge. Stealth influenza virus replication precedes the initiation of adaptive immunity. J. Immunol. 183, 3569-3573
14. Wolff, T., and Ludwig, S. (2009) Influenza viruses control the vertebrate type I interferon system. Factors, mechanisms, and consequences. J. Interferon Cytokine Res. 29, 549-557
15. Hale, B. G., Randall, R. E., Ortín, J., and Jackson, D. (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89, 2359-2376
16. Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S., and Meier, E. (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62, 51-61
17. Haller, O., Kochs, G., and Weber, F. (2007) Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev. 18, 425-433
18. Ward, S. V., George, C. X., Welch, M. J., Liou, L. Y., Hahm, B., Lewicki, H., de la Torre, J. C., Samuel, C. E., and Oldstone, M. B. (2011) RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 331-336
19. Wang, X., Hinson, E. R., and Cresswell, P. (2007) The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2, 96-105
20. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E., García-Sastre, A., Leib, D. A., Pekosz, A., Knobeloch, K. P., Horak, I., and Virgin, H. W., 4th (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U.S.A. 104, 1371-1376
21. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., Adams, D. J., Xavier, R. J., Farzan, M., and Elledge, S. J. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254
22. Jouvenet, N., Neil, S. J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., Mc- Natt, M., Hatziioannou, T., and Bieniasz, P. D. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83, 1837-1844
23. Pardieu, C., Vigan, R., Wilson, S. J., Calvi, A., Zang, T., Bieniasz, P., Kellam, P., Towers, G. J., and Neil, S. J. (2010) The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitindependent endosomal degradation of tetherin. PLoS Pathog. 6, e1000843
24. Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., and Bates, P. (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 106, 2886-2891
25. Neil, S. J., Zang, T., and Bieniasz, P. D. (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430
26. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., and Guatelli, J. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is down-regulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252
27. Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., and Yasuda, J. (2009) Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83, 2382-2385
28. Blasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S., and Colonna, M. (2006) Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260-3265
29. Ishikawa, J., Kaisho, T., Tomizawa, H., Lee, B. O., Kobune, Y., Inazawa, J., Oritani, K., Itoh, M., Ochi, T., and Ishihara, K. (1995) Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26, 527-534
30. Vidal-Laliena, M., Romero, X., March, S., Requena, V., Petriz, J., and Engel, P. (2005) Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell. Immunol. 236, 6-16
31. Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., and Banting, G. (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4, 694-709
32. Malim, M. H., and Emerman, M. (2008) HIV-1 accessory proteins. Ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398
33. Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007) Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 120, 3850-3858
34. Hammonds, J., Wang, J. J., Yi, H., and Spearman, P. (2010) Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog. 6, e1000749
35. Hinz, A., Miguet, N., Natrajan, G., Usami, Y., Yamanaka, H., Renesto, P., Hartlieb, B., McCarthy, A. A., Simorre, J. P., Göttlinger, H., and Weissenhorn, W. (2010) Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe 7, 314-323
36. Neil, S. J., Sandrin, V., Sundquist, W. I., and Bieniasz, P. D. (2007) An interferon-α-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193-203
37. Habermann, A., Krijnse-Locker, J., Oberwinkler, H., Eckhardt, M., Homann, S., Andrew, A., Strebel, K., and Kräusslich, H. G. (2010) CD317/ tetherin is enriched in the HIV-1 envelope and down-regulated from the plasma membrane upon virus infection. J. Virol. 84, 4646-4658
38. Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M. W., Gregory, D. A., Johnson, M. C., and Bieniasz, P. D. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511
39. Lehmann, M., Rocha, S., Mangeat, B., Blanchet, F., Uji-I, H., Hofkens, J., and Piguet, V. (2011) Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog. 7, e1002456
40. Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J., and Piguet, V. (2009) HIV-1 Vpu neutralizes the antiviral factor tetherin/ BST-2 by binding it and directing its β-TrCP2-dependent degradation. PLoS Pathog. 5, e1000574
41. Douglas, J. L., Gustin, J. K., Viswanathan, K., Mansouri, M., Moses, A. V., and Früh, K. (2010) The great escape. Viral strategies to counter BST-2/ tetherin. PLoS Pathog 6, e1000913
42. Le Tortorec, A., and Neil, S. J. (2009) Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83, 11966-11978
43. Hauser, H., Lopez, L. A., Yang, S. J., Oldenburg, J. E., Exline, C. M., Guatelli, J. C., and Cannon, P. M. (2010) HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7, 51
44. McNatt, M. W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I. B., Johnson, W. E., Neil, S. J., and Bieniasz, P. D. (2009) Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5, e1000300
45. Yondola, M. A., Fernandes, F., Belicha-Villanueva, A., Uccelini, M., Gao, Q., Carter, C., and Palese, P. (2011) Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 85, 2480-2491
46. Watanabe, R., Leser, G. P., and Lamb, R. A. (2011) Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology 417, 50-56
47. Chen, B. J., Leser, G. P., Morita, E., and Lamb, R. A. (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 81, 7111-7123
48. Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T., and Palese, P. (2005) Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79, 8431-8439
49. Lowen, A. C., Steel, J., Mubareka, S., Carnero, E., García-Sastre, A., and Palese, P. (2009) Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J. Virol. 83, 2803-2818
50. Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267
51. Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H., and Clavel, F. (1994) HIV-1 reverse transcription.Atermination step at the center of the genome. J. Mol. Biol. 241, 651-662
52. Miyagi, E., Andrew, A. J., Kao, S., and Strebel, K. (2009) Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U.S.A. 106, 2868-2873
53. Toohey, K., Wehrly, K., Nishio, J., Perryman, S., and Chesebro, B. (1995) Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213, 70-79
54. Ozaki, S., Kosaka, M., Wakatsuki, S., Abe, M., Koishihara, Y., and Matsumoto, T. (1997) Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood 90, 3179-3186
55. Hammonds, J., Ding, L., Chu, H., Geller, K., Robbins, A., Wang, J. J., Yi, H., and Spearman, P. (2012) The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release. J. Virol. 86, 2259-2272
56. Okumura, A., Pitha, P. M., and Harty, R. N. (2008) ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U.S.A. 105, 3974-3979
57. Erikson, E., Adam, T., Schmidt, S., Lehmann-Koch, J., Over, B., Goffinet, C., Harter, C., Bekeredjian-Ding, I., Sertel, S., Lasitschka, F., and Keppler, O. T. (2011) In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc. Natl. Acad. Sci. U.S.A. 108, 13688-13693
58. Ramilo, O., Allman, W., Chung, W., Mejias, A., Ardura, M., Glaser, C., Wittkowski, K. M., Piqueras, B., Banchereau, J., Palucka, A. K., and Chaussabel, D. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077
59. Kochs, G., García-Sastre, A., and Martínez-Sobrido, L. (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81, 7011-7021
60. Chen, Z., Li, Y., and Krug, R. M. (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 18, 2273-2283
61. Caliguiri, L. A., and Holmes, K. V. (1979) Host-dependent restriction of influenza virus maturation. Virology 92, 15-30
62. Salvatore, M., Basler, C. F., Parisien, J. P., Horvath, C. M., Bourmakina, S., Zheng, H., Muster, T., Palese, P., and García-Sastre, A. (2002) Effects of influenza A virus NS1 protein on protein expression. The NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76, 1206-1212
63. Henkel, J. R., Gibson, G. A., Poland, P. A., Ellis, M. A., Hughey, R. P., and Weisz, O. A. (2000) Influenza M2 proton channel activity selectively inhibits trans-Golgi network release of apical membrane and secreted proteins in polarized Madin-Darby canine kidney cells. J. Cell Biol. 148, 495-504
64. Mibayashi, M., Martinez-Sobrido, L., Loo, Y. M., Cardenas, W. B., Gale, M., Jr., and Garcia-Sastre, A. (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of β interferon by the NS1 protein of influenza A virus. J. Virol. 81, 514-524
65. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H., and Egorov, A. (2004) Immunogenicity and protection efficacy of replication- deficient influenza A viruses with altered NS1 genes. J. Virol. 78, 13037-13045
66. Kawada, J., Kimura, H., Kamachi, Y., Nishikawa, K., Taniguchi, M., Nagaoka, K., Kurahashi, H., Kojima, S., and Morishima, T. (2006) Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. J Gen Virol 87, 1677-1683
67. Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S., and Hacohen, N. (2001) The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875
68. Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., and Rice, C. M. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485